Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 11, 2018 9:30 AM - Nov 13, 2018 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

15th DIA Japan Annual Meeting 2018

Innovative technologies such as AI, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us to discuss these topics.

[V3-S3] TransCelerate: Innovation through Collaboration

Session Chair(s)

Norie  Miki-Yasuda, PhD

Norie Miki-Yasuda, PhD

Head of Clinical Operations Europe, Canada, Australia & New Zealand

Boehringer Ingelheim Pharma GmbH & Co. KG, Germany

“If you want to go fast, go alone; if you want to go far, go together.” Harnessing the power of collaboration can truly alter the healthcare landscape. This session will present TransCelerate’s perspectives around the next generation of collaborations. How will we need to work together differently as regulators, sponsors, patients, sites, and technologists are brought together? How can collaborations defy the bounds of innovation and accelerate disease prevention, diagnosis, treatment, and?—?ultimately?—?cures? This thought-provoking conversation will bring together a diverse panel of senior executives from TransCelerate Member Companies to discuss the many solutions that have been developed across 19 companies to evolve the clinical trials paradigm. Attendees will learn about how TransCelerate has been solving challenges with Regulators in the Pharmacovigilance space, redefining the Site Investigator experience through novel technologies, and utilizing model frameworks for eConsent and eLabels to progress the industry towards digitally-supported, patient-centric trials.

Speaker(s)

Gareth H Morgan, MBA, MS

An Overview of TransCelerate BioPharma, Inc.

Gareth H Morgan, MBA, MS

Shionogi USA Inc., United States

Vice President, Management & Clinical Development

Toshiharu  Sano, RPh

TransCelerate Activities in Japan

Toshiharu Sano, RPh

Japan Pharmaceutical Manufacturers Association, Japan

Vice-Chairperson, Drug Evaluation Committee

Ken  Kubota, PhD

Key Initiative Update: Pharmacovigilance

Ken Kubota, PhD

Astellas Pharma Inc., United States

Vice President for Pharmacovigilance Operations

Kouichi  Mitsuhashi

Key Initiative Update: SIP (Shared Investigator Platform)

Kouichi Mitsuhashi

MSD K.K., Japan

RBSL, Clinical Operations

Yosuke  Chiyomori

eLabels in Clinical Supplies

Yosuke Chiyomori

Eli Lilly Japan K.K., Japan

Clinical Development Manager, Trial Mgmt,Clinical Development Ops & Innovations

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.